The open-source pipeline designs proteins with improved success rates for therapeutic targets, including gene editing proteins and allergens.

Blueprint for ovarian reserve cell development identifies critical development milestones, risk factors for hormone-related disorders.

Researchers have created a blueprint of how one of the world's most dangerous toxins, botulinum toxin, is structured, stabilized, delivered and released.

Antibodies from a person who had previously been infected with mpox provides full protection from severe illness and death in mice.

Intuitive Machines and San Jacinto College are working on a training program for space-made biopharmaceuticals.

Building greener bioprocessing in any country is a large task. In the UAE, though, completing large tasks is not new.

A scalable, standardized platform to produce consistent, high-quality extracellular vesicles (EVs) from induced mesenchymal stem cells (MSCs) was developed recently by researchers at Allife Medicine ...

Popular gene editing tools, such as CRISPR-Cas9, which are often used for creating a new host cell line for producing commercial biotherapeutics, require a specific license, and the intellectual ...

DeepMVP might eventually be applied to cancer, neurological conditions, and cardiovascular diseases, and accelerate discoveries in genetics.

AbbVie has agreed to acquire Gilgamesh Pharmaceuticals’ lead pipeline asset bretisilocin, a clinical-stage candidate designed to treat moderate-to-severe major depressive disorder (MDD), for up to $1.

How lipid nanoparticles shape dendritic cell responses has been uncovered, offering insight into safer vaccines and potential autoimmune disease therapies.

Findings suggest that because the brain maps are preserved, it may, theoretically, be possible to restore movement to a ...